Home testing for sleep apnea to improve well-being in patients with atrial fibrillation
Official title: National Decentral/Virtual Randomized Trial Testing Remote Sleep Apnea Evaluation in Patients With Atrial Fibrillation
Run by Herlev and Gentofte Hospital · NCT06618417 · Data updated 2026-11-12
This study is testing if home testing and treatment for sleep apnea can help people with atrial fibrillation feel better and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 936 (estimated) |
| Sponsor | Herlev and Gentofte Hospital Academic / other |
| Locations | 1 site (Hellerup) |
| Status | Recruiting |
| Started | December 5, 2024 |
| Main results expected | February 1, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | August 26, 2026 |
| Trial ID | NCT06618417 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with established paroxysmal or persistent atrial fibrillation who own a compatible smartphone.
✕Probably not a fit
Patients with advanced heart failure, previous investigations for sleep-disturbed breathing, or those who are pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate whether home-based testing for sleep apnea can enhance the well-being of individuals diagnosed with atrial fibrillation. Approximately 936 participants will be randomly assigned to either receive sleep apnea testing and treatment or not receive any testing. The study will track participants' well-being and heart-related symptoms through a mobile app over 18 weeks, measuring quality of life improvements using the Atrial Fibrillation Effect on QualiTy-of-life (AFEQT) questionnaire. The hypothesis is that those tested and treated for sleep apnea will show a significant improvement in their quality of life scores compared to those who are not tested.
Why it matters
Potential benefit: If successful, this approach could lead to improved quality of life and health outcomes for patients with atrial fibrillation by effectively managing sleep apnea.
How similar studies have gone: Other studies have indicated the importance of managing sleep apnea in patients with atrial fibrillation, suggesting that this approach may yield beneficial results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Established paroxysmal or persistent AF diagnosis * Owning a compatible smartphone * 18 years or older Exclusion Criteria: * Previous investigation for sleep-disturbed breathing * Advanced heart failure (left ventricular dysfunction and NYHA III/IV) * Occupational driver licenses * Pregnancy * Doxazosin or Terazosin treatment (alpha-adrenergic antagonists) * Peripheral arterial disease with daily intermittent claudication
Where it's running
-
Herlev-Gentofte Hospital
Hellerup, Denmark Recruiting
Study contacts
- Study coordinator: Morten Kjøbek Lamberts ML Associate Professor Lamberts
- Email: morten.kjoebek.lamberts@regionh.dk
- Phone: +45 22434186
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation
This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.
-
Oura Ring validation for sleep using gold-standard sleep tests
This study tests how well the Oura Ring matches the gold-standard sleep test ( PSG ) in healthy adults and people with sleep apnea.
-
Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation
This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.
-
Bachmann’s Bundle Pacing vs Right Atrial Appendage Pacing for AF
This study tests two common atrial pacing methods to see which one is safer over 12 months for people getting a new pacemaker, ICD, or CRT device.
-
Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities
This study tests how comorbid conditions like sleep apnea and primary aldosteronism relate to left-atrial fibrosis and AF recurrence in patients undergoing ablation.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.